The major house dust mite
allergens Der p 1 and
Der p 2 are prevalent inducers of
eczema.
Der p 1 is a
cysteine protease disrupting epithelial barriers, whereas
Der p 2 functionally mimics the LPS-binding compound MD-2 within the TLR4 complex. In this work, we tested the percutaneous sensitizing capacity of recombinant (r)
Der p 1 and
Der p 2 in BALB/c mice. Mice were sensitized by percutaneous application of low (10 μg/application) and high dose (100 μg) rDer p 1 or rDer
p 2, or with rDer p 1 followed by rDer
p 2.
Allergen-specific and total
IgE antibodies were determined by ELISA.
Eczema of BALB/c was classified by the
itching score and corresponded to erosions. Infiltrating immune cells were identified by haematoxylin/
eosin and Giemsa staining for eosinophils or mast cells, CD3 staining for T lymphocytes. Percutaneous treatments with rDer p 1, but not rDer p 2-induced specific
IgG1. However, cotreatment with rDer p 1 led to increase in anti-
Der p 2 IgG titres. Both
allergens elicited skin erosions because of scratching, thickening of the epidermis, and eosinophil and T-cell infiltration. Our data indicate that recombinant mite
allergens in the absence of adjuvant are sufficient for inducing
eczema in BALB/c mice. As the enzymatic activity of an
allergen might be an important cofactor for specific sensitization via the skin,
Der p 1 may act as adjuvant for other
allergens too. The presented mouse model is suitable for investigating the mechanisms of allergic
eczema.